Edition:
United States

IsoRay Inc (ISR.A)

ISR.A on American Stock Exchange

0.60USD
27 Apr 2017
Change (% chg)

$-0.02 (-3.34%)
Prev Close
$0.62
Open
$0.62
Day's High
$0.62
Day's Low
$0.57
Volume
25,086
Avg. Vol
19,441
52-wk High
$1.19
52-wk Low
$0.48

ISR.A

Chart for ISR.A

About

IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy... (more)
No analyst recommendations are available for ISR.A.

Overall

Beta: -0.89
Market Cap(Mil.): $33.09
Shares Outstanding(Mil.): 55.02
Dividend: --
Yield (%): --

Financials

  ISR.A Industry Sector
P/E (TTM): -- 58.41 30.30
EPS (TTM): -0.10 -- --
ROI: -31.55 0.45 13.24
ROE: -33.24 6.31 14.40

BRIEF-Isoray announces final court approval of class action settlement

* Isoray announces final court approval of class action settlement Source text for Eikon: Further company coverage:

Mar 09 2017

BRIEF-IsoRay Q2 loss per share $0.03

* Says continues to expect stronger second half of fiscal 2017

Feb 08 2017

BRIEF-Isoray Inc's CFO Brien Ragle to resign

* Isoray Inc -on January 16, 2017, Brien Ragle, CFO of co, informed board of his resignation from all positions held with co and its subsidiaries, effective immediately

Jan 17 2017

More From Around the Web

Competitors

Earnings vs. Estimates